News Center

KKR looks to deploy $116 billion cash in choppy market after profit boost

KKR looks to deploy $116 billion cash in choppy market after profit boost

By Niket Nishant (Reuters) - Investment giant KKR is ready to put its $116 billion of capital to use as market volatility creates fresh opportunities, it said after posting a nearly 20% jump in first-quarter profit on Thursday. While tariff-driven turbulence has stirred concerns over limited exit opportunities, top KKR executives said its global footprint and asset mix have put it in a better posi ...

2025-05-02 03:50:40
Goldman Sachs updates conviction lists: Adds Johnson & Johnson and Axis Bank

Goldman Sachs updates conviction lists: Adds Johnson & Johnson and Axis Bank

Investing.com -- Goldman Sachs has refreshed its Conviction Lists for both the U.S. and Asia-Pacific regions, highlighting additions that reflect resilience, growth potential, and valuation upside. Johnson & Johnson (NYSE:JNJ) and Houlihan Lokey (NYSE:HLI) were added to the U.S. list, while Axis Bank (NSE:AXBK) joined the APAC roster alongside Horizon Robotics and NextDC.In the U.S ...

2025-05-02 03:49:40
Big Tech’s fortunes diverge as AI powers cloud, tariffs hit consumer electronics

Big Tech’s fortunes diverge as AI powers cloud, tariffs hit consumer electronics

By Aditya Soni and Deborah Mary Sophia (Reuters) -The fortunes of Big Tech are diverging in a rapidly changing business landscape, as demand for artificial intelligence fuels growth in cloud and digital ads while consumer electronics take a battering from President Donald Trump’s global trade war. AI came to the rescue of earnings at Microsoft (NASDAQ:MSFT) and Google-parent Alphabet (NASDAQ:GOO ...

2025-05-02 03:48:40
Moderna says FDA has been constructive, but delays flu/COVID shot

Moderna says FDA has been constructive, but delays flu/COVID shot

By Patrick Wingrove and Michael Erman (Reuters) -Moderna on Thursday pushed back the time frame for likely approval of a combination vaccine meant to protect against both COVID-19 and influenza, but said exchanges with U.S. drug regulators have remained constructive under Health Secretary and vaccine skeptic Robert F. Kennedy Jr. The U.S. vaccine maker reported first-quarter profit and sales that ...

2025-05-02 03:47:42